Physician profile
Wei Quan How
NPI 1922528330
$8,949.65
in general payments reported to CMS, 2019-2025
38 companies · $6,443 in 2025
The $6,443 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.95 · 2020: $27.19 · 2021: $372 · 2022: $573 · 2023: $792 · 2024: $725 · 2025: $6,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,750 · Food and Beverage: $2,292 · Travel and Lodging: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,750.00 |
| Food and Beverage | $2,292.08 |
| Travel and Lodging | $917.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,949.43 | 2022-2025 | |
| Davol INC. | $973.40 | 2022-2025 | Phasix Mesh |
| Novo Nordisk INC | $227.30 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $214.01 | 2022-2024 | Xifaxan, Plenvu |
| Csl Behring | $149.36 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $136.38 | 2022-2024 | Verquvo, Belsomra, Steglatro |
| Lundbeck LLC | $127.62 | 2022-2024 | Rexulti |
| Amgen INC. | $122.31 | 2022-2025 | Evenity, Prolia, Krystexxa |
| Ethicon US, LLC | $119.80 | 2021 | |
| Innocoll Pharmaceuticals Limited | $108.14 | 2021 | |
| Gilead Sciences, INC. | $68.58 | 2024-2025 | |
| Boston Scientific Corporation | $61.24 | 2022-2023 | Solyx Sis System |
| Abbvie INC. | $52.74 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $51.43 | 2023-2024 | Xarelto |
| Lilly USA, LLC | $48.44 | 2024 | Mounjaro, Zepbound |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Quan How listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.